stericycle is a global services company. we provide highly specialized solutions serving healthcare organizations and commercial businesses of every size and shape. throughout the last 25 years, we have grown from a small start-up in medical waste management into a leader across a range of increasingly complex and highly regulated arenas, such as: • brand protection solutions • environmental & sustainable solutions • patient & customer communication solutions • regulated waste management & compliance solutions from the start we have challenged the status quo of what a business solution can be. by identifying unmet needs, we have redefined and transformed multiple industries from a narrowly defined service category to a robust suite of solutions that customers need and want. our success with this strategy has landed stericycle among the fortune 1000 list and forbes 25 most innovative companies. a publicly-traded company with $2.5 billion in 2014 revenue, our core purpose is to
Company profile
Ticker
SRCL
Exchange
Website
CEO
Cindy Miller
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
Corporate docs
Subsidiaries
Stericycle International, LLC • Stericycle Management, LLC • Stericycle of Washington, Inc. • SteriVentures, LLC • Stroud Properties, Inc. • Shred-it Insurance Limited • Stericycle, ULC • SRCL Cyprus Ltd. • Shred-it GmbH • SRCL Ireland Limited ...
IRS number
363640402
SRCL stock data
Latest filings (excl ownership)
10-Q
2024 Q1
Quarterly report
25 Apr 24
8-K
Stericycle, Inc. Reports Results For The First Quarter 2024
25 Apr 24
ARS
2023 FY
Annual report to shareholders
5 Apr 24
DEFA14A
Additional proxy soliciting materials
5 Apr 24
DEF 14A
Definitive proxy
5 Apr 24
10-K
2023 FY
Annual report
28 Feb 24
8-K
Stericycle, Inc. Reports Results For The Fourth Quarter 2023
28 Feb 24
8-K
Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
2 Feb 24
10-Q
2023 Q3
Quarterly report
2 Nov 23
8-K
Stericycle, Inc. Reports Results For the Third Quarter 2023
2 Nov 23
Transcripts
SRCL
Earnings call transcript
2024 Q1
25 Apr 24
SRCL
Earnings call transcript
2023 Q4
28 Feb 24
SRCL
Earnings call transcript
2023 Q3
2 Nov 23
SRCL
Earnings call transcript
2023 Q2
27 Jul 23
SRCL
Earnings call transcript
2023 Q2
27 Jul 23
SRCL
Earnings call transcript
2023 Q1
27 Apr 23
SRCL
Earnings call transcript
2022 Q4
23 Feb 23
SRCL
Earnings call transcript
2022 Q3
3 Nov 22
SRCL
Earnings call transcript
2022 Q2
5 Aug 22
SRCL
Earnings call transcript
2022 Q1
28 Apr 22
Latest ownership filings
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 29.70 mm | 29.70 mm | 29.70 mm | 29.70 mm | 29.70 mm | 29.70 mm |
Cash burn (monthly) | 333.33 k | 1.19 mm | (no burn) | (no burn) | (no burn) | (no burn) |
Cash used (since last report) | 2.30 mm | 8.21 mm | n/a | n/a | n/a | n/a |
Cash remaining | 27.40 mm | 21.49 mm | n/a | n/a | n/a | n/a |
Runway (months of cash) | 82.2 | 18.0 | n/a | n/a | n/a | n/a |
Institutional ownership, Q3 2023
13F holders | Current |
---|---|
Total holders | 316 |
Opened positions | 30 |
Closed positions | 51 |
Increased positions | 106 |
Reduced positions | 114 |
13F shares | Current |
---|---|
Total value | 4.21 tn |
Total shares | 94.22 mm |
Total puts | 101.80 k |
Total calls | 356.90 k |
Total put/call ratio | 0.3 |
Largest owners | Shares | Value |
---|---|---|
Vanguard | 8.92 mm | $398.66 bn |
Alliancebernstein | 7.94 mm | $355.22 bn |
BLK Blackrock | 7.73 mm | $345.43 bn |
Clarkston Capital Partners | 6.52 mm | $291.70 bn |
Black Creek Investment Management | 5.49 mm | $245.63 bn |
Capital Research Global Investors | 5.28 mm | $236.17 bn |
Ariel Investments | 4.33 mm | $193.51 bn |
T. Rowe Price | 3.82 mm | $173.52 bn |
Impax Asset Management | 2.99 mm | $132.80 bn |
STT State Street | 2.61 mm | $116.56 bn |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
15 Mar 24 | Richard J Hoffman | Common Stock | Payment of exercise | Dispose F | No | No | 52.3 | 479 | 25.05 k | 21,345 |
15 Mar 24 | Richard J Hoffman | Common Stock | Option exercise | Acquire M | No | No | 0 | 1,633 | 0.00 | 21,824 |
15 Mar 24 | Richard J Hoffman | Common Stock | Payment of exercise | Dispose F | No | No | 52.3 | 347 | 18.15 k | 20,191 |
15 Mar 24 | Richard J Hoffman | Common Stock | Option exercise | Acquire M | No | No | 0 | 1,199 | 0.00 | 20,538 |
15 Mar 24 | Richard J Hoffman | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 1,633 | 0.00 | 8,569 |
15 Mar 24 | Richard J Hoffman | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 1,199 | 0.00 | 10,202 |
15 Mar 24 | Miller Cindy J | Common Stock | Payment of exercise | Dispose F | No | No | 52.3 | 6,842 | 357.84 k | 116,954 |
15 Mar 24 | Miller Cindy J | Common Stock | Option exercise | Acquire M | No | No | 0 | 15,763 | 0.00 | 123,796 |
15 Mar 24 | Miller Cindy J | Common Stock | Payment of exercise | Dispose F | No | No | 52.3 | 4,919 | 257.26 k | 108,033 |
15 Mar 24 | Miller Cindy J | Common Stock | Option exercise | Acquire M | No | No | 0 | 11,332 | 0.00 | 112,952 |
News
Baird Maintains Neutral on Stericycle, Lowers Price Target to $55
26 Apr 24
Stericycle CEO Says "We remain on track to achieve our full-year 2024 guidance and long-term outlook."
25 Apr 24
Stericycle Q2 2024 GAAP EPS $0.57, Inline, Sales $664.900M Miss $679.277M Estimate
25 Apr 24
Warehouse Workers At Stericycle Vote Unanimously To Join Teamsters Local 251
16 Apr 24
RBC Capital Reiterates Outperform on Stericycle, Maintains $69 Price Target
7 Mar 24